Anti-inflammatory Drugs Market to Grow Steadily Over CAGR of 9.80%

The latest market report published by Credence Research, Inc. “Global Anti-inflammatory Drugs Market: Growth, Future Prospects, and Competitive Analysis, 2016 – 2028. The global anti-inflammatory drugs market has grown steadily in recent years and is predicted to increase at a 9.80% CAGR between 2023 and 2030. In 2022, the market was valued at USD 100.9 billion, and it is predicted to grow to USD 194.1 billion by 2030.

The global anti-inflammatory drugs market is driven by various factors, including the increasing prevalence of inflammatory diseases and the presence of potential pipeline candidates. However, the market faces challenges such as the side effects of NSAIDs, stringent regulatory requirements, and competition from generic drugs.

Anti-inflammatory Drugs Market Drivers refer to the factors that are propelling the growth of this industry. One of the main drivers is the increasing prevalence of chronic diseases, such as arthritis and cancer, which require long-term treatment with anti-inflammatory drugs. Another factor driving market growth is rising healthcare expenditure across the globe, particularly in developing countries where there has been a surge in demand for affordable and effective medication. Additionally, advancements in technology have led to improved drug delivery methods and enhanced efficacy of these drugs. Moreover, growing awareness among consumers about preventive healthcare measures has also contributed to increased demand for anti-inflammatory drugs. The rise in geriatric population worldwide who suffer from age-related inflammatory conditions has further augmented market expansion opportunities. Furthermore, government initiatives aimed at improving access to essential medicines are expected to drive growth in emerging markets over time.

Despite the challenges, the global anti-inflammatory drugs market offers significant growth prospects, including advancements in biotechnology and the introduction of novel anti-inflammatory medications. While the Asia-Pacific region is expected to witness the highest growth, North America currently holds the largest market share for anti-inflammatory drugs.

The report provides a comprehensive market overview, defining the global anti-inflammatory drugs market and identifying key players. The market was valued at USD 100.9 billion in 2022 and is projected to reach USD 194.1 billion by 2030, growing at a CAGR of 9.80% between 2023 and 2030.

Key players in the global anti-inflammatory drugs market include AbbVie Inc., Merck & Co., Inc., Bristol-Myers Squibb Company, Johnson & Johnson Services, Inc., Pfizer Inc., Novartis AG, GlaxoSmithKline plc., Eli Lilly and Company, Amgen Inc., Biogen, and others. These companies focus on product innovation, expanding their distribution channels, and strategic mergers and acquisitions to maintain a competitive edge.

Why to Buy This Report-

  • The report provides a qualitative as well as quantitative analysis of the global Anti-inflammatory Drugs Market by segments, current trends, drivers, restraints, opportunities, challenges, and market dynamics with the historical period from 2016-2020, the base year- 2021, and the projection period 2022-2028.
  • The report includes information on the competitive landscape, such as how the market’s top competitors operate at the global, regional, and country levels.
  • In-depth analysis of the global market segmentation on the Route of Administration and  Application
  • Major nations in each region with their import/export statistics
  • The global Anti-inflammatory Drugs Market report also includes the analysis of the market at a global, regional, and country-level along with key market trends, major players analysis, market growth strategies, and key application areas.

Browse Full Report:


Related Report:

Related Report:

Browse Our Blog:

Leave a Reply

Your email address will not be published.